Millions of individuals all over the world take antidepressants. While these drugs might be very effective in treating mental health conditions resembling depression and anxiety, they may also cause a spread of physical unintended effects—including weight gain, heart rate changes, and blood pressure changes.
Not all antidepressants are equal in terms of this Physiological effects They could also be on the body, a brand new evaluation published by myself and my colleagues. We found Clear and meaningful differences Among drugs, some have greater effects on weight, heart rate, levels of cholesterol and blood pressure. For the tens of millions of people that take these pharmaceuticals, these differences matter.
Our study pooled 151 randomized trials with data on 58,534 people and checked out 30 different antidepressants. In each study, the standard physiological measures you see in a clinic were recorded, resembling blood pressure, body weight and heart rate. Most studies lasted about eight weeks.
We then used a technique called network meta-analysis, which means that you can compare multiple treatments against one another at the identical time. This approach gives a kind of “league table” of treatments, rating them from best to worst for every physical health consequence.
We found that even after only eight weeks of treatment, the physiological effects of various antidepressants weren’t subtle.
Weight effects vary markedly between drugs. For example, people taking the antidepressant agomelatine lost a median of two.5 to 2.5 kilograms, while those on maprotiline gained about 2.2 kilograms.
Heart rate effects also vary widely. The antidepressant fluvoxamine actually lowered heart rate by eight beats per minute, while nortriptyline raised it to about 14 — a difference of greater than 20 beats per minute between the drugs.
The difference in systolic blood pressure between the antidepressants doxepin and nortriptyline was greater than 11 mm Hg.
And for cholesterol and blood sugar levels, several antidepressants — including paroxetine, venlafaxine, desvenlafaxine and duloxetine — were related to higher total cholesterol. Duloxetine was also related to higher blood sugar levels.
It is significant to notice that the evaluation focused only on antidepressant treatment that lasted roughly eight weeks. Because many individuals take antidepressants for longer than this, the real-world, long-term physiological effects could also be greater. This is one reason why routine monitoring of patients taking antidepressants is significant.
We also only included objective outcomes that were consistently collected across trials. Some necessary physical issues, resembling sexual unintended effects, will not be routinely measured in research and so weren’t included within the evaluation because of lack of information—not lacking significance. It can be necessary for future studies to research such findings.
Antoniodias/Shutterstock
The results shouldn't be read as a listing of “good” and “bad” antidepressants. Rather, they illustrate how different drugs can have different physiological effects. Our research goals to point out why prescribing is significant for every patient.
peronalized prescription
For years, the controversy about antidepressants has been “do they work?” has been developed as or “Are the side effects real?” Our findings suggest a more useful query: Which drug suits which person in accordance with their physical health and preferences?
Data show that antidepressants will not be interchangeable. For someone with obesity, diabetes, or hypertension, selecting an antidepressant that has a more neutral effect on weight, blood sugar, and blood pressure is smart. But for an underweight person with low blood pressure, the trade-off could also be different. The exact answer will depend upon the patient.
In light of our recent findings, it’s more necessary than ever that doctors work with patients to know their preferences and match them with the fitting antidepressant.
Of course, this can be a challenge in and of itself for doctors, who will need to contemplate two dozen different antidepressants and their many potential unintended effects. So together with the evaluation that we did, we also developed earlier Freely available tool That doctors and patients can use together to come to a decision on the fitting antidepressant.
This tool allows doctors and patients to decide on the unintended effects that the patient desires to avoid as much as possible and determine how necessary each is. The tool then correlates those preferences with a database of unintended effects, then creates a customized table of options based on which antidepressants best fit the patient's preferences.
Antidepressants are effective for many individuals. Our study doesn’t change this. But what this does show is that not all antidepressants are the identical. We now have high-quality evidence that they differ in clinically meaningful ways on weight, blood pressure, heart rate and blood sugar.
Instead of arguing for or against antidepressants as a gaggle, we must always concentrate on matching the medication to the person, with decisions made jointly between doctor and patient.
Tools like One we have built Make this possible, in order that patients might be prescribed antidepressants which might be safer and higher tolerated.